BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ERYtech Pharma 

60, avenue Rockefeller
Bâtiment Adénine
Lyon    69008  France
Phone: 33-0-4-78-744438 Fax: 33-0-4-78-755629


SEARCH JOBS


Industry
Biotechnology






 Company News
ERYtech Pharma Picks Up A New Candidate For Its Tumor Starvation Pipeline 4/9/2014 6:44:21 AM    More...
ERYtech Pharma Receives Orphan Drug Designation By The FDA For ERY-ASP In Acute Myeloid Leukemia 4/2/2014 9:40:13 AM    More...
LifeSci Advisors Initiates Coverage Of ERYtech Pharma 3/20/2014 11:20:40 AM    More...
ERYtech Pharma Gives Feedback On Its First Investor R&D Day And Provides A Financial And Business Update For Q4 2013 1/28/2014 8:02:05 AM    More...
ERYtech Pharma Announces Clinical Trial Authorizations In Finland And Spain For Its European Phase 2b Study In AML 1/15/2014 8:47:18 AM    More...
ERYtech Pharma Positions Its Lead Product In Solid Tumors And Launches A Phase II Clinical Study In Pancreatic Cancer 1/7/2014 8:53:24 AM    More...
ERYtech Pharma Announces The Decision Of USPTO To Extend The Additional Exclusivity Period Of Its Core Process Patent To Almost 4 Years 12/20/2013 9:41:30 AM    More...
ERYtech Pharma Announces Two Presentations At 55th American Society of Hematology Annual Meeting And Exposition In New Orleans 12/9/2013 6:58:04 AM    More...
ERYtech Pharma Announces Two Presentations At 55th American Society of Hematology Annual Meeting And Exposition In New Orleans 12/6/2013 6:25:11 AM    More...
ERYtech Pharma Announces Positive DSMB Review Of Its Phase 2b Study In Acute Myeloid Leukemia 11/11/2013 2:54:44 PM    More...
1234

//-->